findmyKOL

Prabhleen Singh, MD

Basic profile

University of California San Diego

ORCIDNPI
RegionSan Diego, CA · WestSpecialtyNephrologyFocusNephrology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH funding2010–2025

Prabhleen Singh is a Nephrology physician affiliated with University of California San Diego. OpenAlex indexes 83 publications with 2,406 citations (h-index 26).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
83publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,406citations

Total citations across indexed works.

26h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
5NIH grants · 2010–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3350 La Jolla Village Dr
Mc 111h
San Diego, CA 921610002

Telephone

858-552-7528

Provider last certified this registry record 15 Sept 2020.

View the NPPES registry record

Industry payments

1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    87%
    Loop diuretic28.1%
    Furosemide84%Bumetanide16%
    Part D<11 patients
    Calcium channel blocker26%
    Amlodipine Besylate61%Nifedipine Er39%
    Part D<11 patients

    + 4 more classes in this area

  • Metabolism & gastrointestinal

    9.1%
    SGLT2 inhibitor9.1%
    Jardiance100%
    Part D<11 patients
  • Hormonal (systemic)

    3.9%
    Mineralocorticoids3.9%
    Fludrocortisone Acetate100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

5 NIH research awards on record, funded 20102025 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”